SIRT6 and type 2 diabetes mellitus: In addition, sirt6 may positively mediate glucose stimulated insulin secretion and overexpression of sirt6 enhances insulin sensitivity in skeletal muscle and liver, which implicates that sirt6 may act as an attractive therapeutic target for T2D [138].